课题基金 / 基金详情

Assessing the Impact of Genetic Modifications on Chimeric Antigen Receptor (CAR) T-Cell Proliferation Capacity and Persistence

Assessing the Impact of Genetic Modifications on Chimeric Antigen Receptor (CAR) T-Cell Proliferation Capacity and Persistence
评估基因修饰对嵌合抗原受体 (CAR) T 细胞增殖能力和持久性的影响
批准号：
428962
负责人：
Maru Bruktawit
金额：
$1.27万
依托单位：
McGill University
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2019
资助国家：
加拿大
项目状态：
已结题
起止时间：
2019-12-01 至 2020-12-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=428962&lang=en
关键词：
Acute Lymphoblastic Leukemia Adaptive T-Cell Expansion And Persistance Cancer Research Chimeric Antigen Receptor (Car) T-Cells Cyclophosphamide Resistance Genetic Engineering Immunotherapy Lymphodepletion Synthetic Biology

项目摘要

项目成果

Maru Bruktawit的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
"Cancer is the leading cause of death across the globe. There is substantial research being done to develop a curative treatment with minimal side effects. However, these efforts are challenged by the complexity of cancer cells. They have mechanisms in pl
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Predictive Biomarkers for Efficacy of Cytarabine in Acute Myeloid Leukemia Therapeutics
  • 批准号：
    475822
  • 项目类别：
    Studentship Programs
  • 资助金额：
    $7.65万
  • 财政年份：
    2022
  • 负责人：
    Maru Bruktawit
  • 依托单位：
    McGill University